NCT06786650View on ClinicalTrials.gov

Comparision of the Analgesic Effects of Intravenous Ibuprofen and Tenoxicam in Acute Migraine Attack

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 15, 2024

Primary Completion Date

October 15, 2024

Study Completion Date

June 30, 2025

Conditions
MigraineAnalgesic AffectEmergency Medicine
Interventions
DRUG

Tenoxicam Injectable Product

Analgesic efficacy of the two active agents analysed in our study in acute migraine attack has not been compared before.

DRUG

ibuprofen

Analgesic efficacy of the two active agents analysed in our study in acute migraine attack has not been compared before.

Trial Locations (1)

34843

Haydarpasa Numune Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Haydarpasa Numune Training and Research Hospital

OTHER

NCT06786650 - Comparision of the Analgesic Effects of Intravenous Ibuprofen and Tenoxicam in Acute Migraine Attack | Biotech Hunter | Biotech Hunter